AI for Health Summit 2022

🇬🇧 AI ready enterprise platform - Unleashing Consumption-Based AI with an End-to-End Platform

Nov 16, 2022 | 10:20 AM CET - 10:40 AM CET

Description

Hewlett Packard Enterprise and NVIDIA® are advancing healthcare research and development through greater insight, improved productivity, and faster time to discovery. Designed to manage and analyze massive amounts of data, these solutions facilitate all workflows to accelerate the most impactful work and improve healthcare outcomes. Our NVIDIA AI Enterprise platform is built on NVIDIA-certified HPE systems and enables GPU-accelerated applications to accelerate the innovation process and maximize return on investment. The platform combines compute, storage, interconnects, software, and services - for an end-to-end solution. Organizations can choose from a wide selection of HPE systems designed for AI and powered by NVIDIA GPUs to harness exceptional processing at any scale.

Presented By

Régis Dioulo

Account Manager

Elyes Boughnim

Account Manager

Teaser Sessions

5:20 pm CET - 6:20 pm CET

Startups Masterclass Stage

🇬🇧🇫🇷 Investors Tour - Startups x Investors speed meetings

⬇️ Are you a startup using AI, data in health? Go & meet +10 investors for 5mn speed meeting to present your startup! Prepare your deck and pitch up to 11 of the...

Animated by Christophe FOURLEIGNIE DUC

Chief Operating Officer

10:25 am CET - 10:40 am CET

Startups Masterclass Stage

🇬🇧 New AI solutions for improved cancer diagnosis and optimized treatment

The latest advances in AI revolutionized the field of histopathology. Tribun Health, a computational pathology pioneer, empowers pathology labs and pharma sponsors with...

AI & Computer Vision Director

12:00 pm CET - 12:10 pm CET

Startups Masterclass Stage

🇫🇷 Construire le futur de la psychiatrie de précision dans le parcours de soin de pathologies...

Current approaches to the detection, diagnosis and monitoring of psychiatric disorders rely heavily on the experience of the psychiatrist and on physician-patient...

Yannick Trescos

ResilEyes Therapeutics

CEO & Co-founder

9:55 am CET - 10:05 am CET

🇬🇧 Real World Evidence to Inform Health Decisions : Data and Methodological Considerations for...

VP Analytics And Insight RWE